Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

SuPAR predicts chronic kidney disease progression in Black Americans

Sep. 12, 2018

Daiichi Sankyo discovers bacterial tryptophanase inhibitors

Sep. 10, 2018

BAY-1101042, a potent NO- and heme-independent sGC activator suitable for oral dosing

Sep. 5, 2018

Janssen Pharmaceutica NV synthesizes 5-HT2B receptor antagonists

Sep. 4, 2018

Bristol-Myers Squibb patents receptor-interacting serine/threonine-protein kinase 1 inhibitors

Aug. 31, 2018

Positive topline data presented from phase Ib study of TAR-302 in idiopathic overactive bladder

Aug. 29, 2018

Sunitinib noninferior to nephrectomy in patients with metastatic renal-cell carcinoma

Aug. 29, 2018

Preclinical identification of a potential druggable target for chronic kidney disease

Aug. 29, 2018

Parasite protein protects mice from hemorrhagic cystitis by inducing IL-4 expression

Aug. 28, 2018

Chugai's describes candidate for the treatment of hyperphosphatemia EOS-798

Aug. 21, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...